| FRANKLIN BIOTECHNOLOGY DISCOVERY N (ACC) USD | BIOTECNOLOGÍA | 67,84% | 66,04% | 45,73% | 102,84% |
| BNY MELLON ASIAN OPPORTUNITIES FUND STERLING C (INC) | RVI ASIA EX-JAPÓN | 28,66% | 29,40% | 4,13% | 102,83% |
| J O HAMBRO CAPITAL MANAGEMENT CONTINENTAL EUROPEAN FUND AH USD | RVI EUROPA | 8,79% | 16,55% | 47,45% | 102,83% |
| UBS (LUX) EQUITY FUND - JAPAN (JPY) Q-ACC | RVI JAPÓN | 10,62% | 38,44% | 28,87% | 102,83% |
| CARMIGNAC EMERGENTS A EUR ACC | RVI EMERGENTES | 39,94% | 49,34% | 10,80% | 102,81% |
| JPM EMERGING MARKETS OPPORTUNITIES C (DIST) USD | RVI EMERGENTES | 53,38% | 52,79% | 12,14% | 102,81% |
| GOLDMAN SACHS EMERGING MARKETS CORE EQUITY PORTFOLIO R (CLOSE) USD DIS | RVI EMERGENTES | 49,15% | 63,93% | 25,97% | 102,72% |
| CT (LUX) EUROPEAN GROWTH AND INCOME A EUR DIS | RVI EUROPA CRECIMIENTO | 15,10% | 38,54% | 54,13% | 102,70% |
| GOLDMAN SACHS EMERGING MARKETS CORE EQUITY PORTFOLIO R (CLOSE) GBP DIS | RVI EMERGENTES | 48,91% | 63,27% | 25,45% | 102,68% |
| UBAM - 30 GLOBAL LEADERS EQUITY AHC EUR | RVI GLOBAL | 12,98% | 13,19% | 9,95% | 102,67% |
